Adults with Prader–Willi Syndrome have Weaker Bones: Effect of Treatment with GH and Sex Steroids
- 11 January 2015
- journal article
- Published by Springer Nature in Calcified Tissue International
- Vol. 96 (2) , 160-166
Abstract
Obesity has been considered to have a protective effect against the risk of fractures in adults. However, a high frequency of fracture is described in obese adults with Prader–Willi syndrome. To evaluate bone geometry, density and strength in a group of adult obese patients with Prader–Willi syndrome (PWS) and to examine the modulating effect on bone of treatment with growth hormone (GH) and sex steroids. This was a cross-sectional study performed in 41 (17 males, 24 females) obese subjects with genetically confirmed PWS, aged 29.4 ± 8.6 years. Forty-six healthy subjects (22 males and 24 females) served as controls. Digitalized X-rays were evaluated at the level of the 2nd metacarpal bone to assess bone geometry, i.e. cross-sectional area (CSA), cortical area (CA), medullary area (MA), metacarpal index (MI) and bone strength evaluated as bending breaking resistance index (BBRI). DEXA was also used to evaluate body composition and bone mineral density (total body, lumbar spine and femoral neck). PWS subjects, after adjusting for height and bone size, had a reduced CSA, CA and BBRI, while bone density was not different. GH treatment had a positive effect and sex steroids a negative effect on bone size and strength. PWS subjects showed a reduced bone size at the metacarpus leading to a reduced strength, while bone density was appropriate for size. GH treatment improves bone geometry but not bone density. Bone strength was significantly reduced in PWS patients who did not receive GH and had been treated with sex steroids.Keywords
This publication has 33 references indexed in Scilit:
- Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2013
- The Role of GH/IGF-I-Mediated Mechanisms in Sex Differences in Cortical Bone Size in MiceCalcified Tissue International, 2010
- IGF-1 and bone: New discoveries from mouse modelsJournal of Bone and Mineral Research, 2010
- Long-Term Growth Hormone Therapy Changes the Natural History of Body Composition and Motor Function in Children with Prader-Willi SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2010
- The Role of Liver-Derived Insulin-Like Growth Factor-IEndocrine Reviews, 2009
- Bone mineral density in prepubertal obese and control children: relation to body weight, lean mass, and fat massJournal of Bone and Mineral Metabolism, 2008
- Circulating adiponectin levels, body composition and obesity-related variables in Prader–Willi syndrome: comparison with obese subjectsInternational Journal of Obesity, 2005
- Insulin resistance and obesity‐related factors in Prader–Willi syndrome: Comparison with obese subjectsClinical Genetics, 2004
- Reduced bone mineral density and increased bone turnover in prader-willi syndrome compared with controls matched for sex and body mass index—a cross-sectional studyThe Journal of Pediatrics, 2004
- Evaluation of cortical thickness and bone density by roentgen microdensitometry in growing males and femalesEuropean Journal of Pediatrics, 1996